Form 4: Thermo Fisher Scientific Executive Holmes Exercises Stock Options and Sells Shares

Sentiment:

SEC Form 4


Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, executed stock options and sold shares on July 26, 2024.

Summary

  • On July 26, 2024, Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, engaged in transactions involving the company's stock.
  • Holmes exercised stock options to acquire 475 shares at $210.68 and 385 shares at $253.99.
  • Simultaneously, Holmes sold 475 shares at $610.67 and 385 shares at $611.47.
  • Following these transactions, Holmes directly owns 1,813.5162 shares of Thermo Fisher Scientific.
  • The transactions were reported on a Form 4 filing with the SEC.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock option exercises and sales. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. They can be influenced by factors such as personal financial planning, company performance, and market conditions.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership.

Key Dates

DateDescription
February 27, 2019First vesting date of one of the stock option grants.
February 26, 2020First vesting date of one of the stock option grants.
February 27, 2020Second vesting date of one of the stock option grants.
February 26, 2021Second vesting date of one of the stock option grants.
February 27, 2021Third vesting date of one of the stock option grants.
February 26, 2022Third vesting date of one of the stock option grants.
February 27, 2022Final vesting date of one of the stock option grants.
February 26, 2023Final vesting date of one of the stock option grants.
May 15, 2024Date of share acquisition under the Issuer's employees' stock purchase plan.
July 26, 2024Date of the stock option exercise and share sale transactions.
February 27, 2025Expiration date of one of the stock option grants.
February 26, 2026Expiration date of one of the stock option grants.
July 29, 2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.